Frontiers in Clinical Neuroscience
Neurodegeneration and Neuroprotection A Symposium in Abel Lajtha’s Honour
Series: Advances in Experimental Medicine and Biology; 541;
- Publisher's listprice EUR 106.99
-
44 374 Ft (42 261 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 8 875 Ft off)
- Discounted price 35 499 Ft (33 809 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
44 374 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2004
- Publisher Springer US
- Date of Publication 30 November 2003
- Number of Volumes 1 pieces, Book
- ISBN 9780306480386
- Binding Hardback
- See also 9781461347408
- No. of pages195 pages
- Size 235x155 mm
- Weight 1050 g
- Language English
- Illustrations IX, 195 p. Illustrations, black & white 0
Categories
Table of Contents:
Advances in Neuroprotection Research for Neurodegenerative Diseases.- Neurotransmitter Release in Experimental Stroke Models: The Role of Glutamate-GABA Interaction.- Neuroprotection in Ischemic/Hypoxic Disorders: From the Preclinical to the Clinical Testing.- Neuroprotection and Dopamine Agonists.- COMT Inhibition in the Treatment of Parkinson’s Disease: Neuroprotection and Future Perspectives.- Neuroprotection and Epilepsy.- Neuroprotection and Glatiramer Acetate: The Possible Role in the Treatment of Multiple Sclerosis.- Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications.- Neuroprotection: A Realistic Goal for Aged Brain?.- Kynurenines in Neurodegenerative Disorders: Therapeutic Consideration.
More
